1,664 filings
Page 17 of 84
8-K
r2sltlgtslla9 tmkxx
28 Oct 15
Other Events
12:00am
8-K
ltru3q4r94
27 Oct 15
Other Events
12:00am
8-K
w17xbz9 fmg
23 Oct 15
Results of Operations and Financial Condition
12:00am
8-K
7wpq 85jhrgn0d
19 Oct 15
Shire Provides Update on Next Steps for Lifitegrast in Light of FDA Complete Response Letter
12:00am
8-K
4juz50 ri
16 Oct 15
Shire to announce third quarter 2015 results
12:00am
8-K
xu93e994j9q yg78rcoe
2 Oct 15
Other Events
12:00am
8-K
vtuumcd4bp7hxoxf4
30 Sep 15
Other Events
12:00am
425
vi4c32 923ha
30 Sep 15
Business combination disclosure
12:00am
8-K
bckp5zk5lrrj0c3ey9
25 Sep 15
Appeals Court Affirms Shire’s Vyvanse® (lisdexamfetamine dimesylate) Patents Are Valid Until 2023
12:00am
425
hyc7e8fd6gum2d
18 Sep 15
Business combination disclosure
12:00am
425
zlm36f6xg1t5vzr
17 Sep 15
Business combination disclosure
12:00am
425
m8wxpr jsa3g8qe
17 Sep 15
Business combination disclosure
12:00am
8-K
etwe9akjw2373nhe70ek
2 Sep 15
Other Events
12:00am
8-K
h80199ir
1 Sep 15
Shire appoints Sara Mathew to Board of Directors
12:00am
8-K
0nxkyur 0vzi
24 Aug 15
Other Events
12:00am
425
kzswhdl0
5 Aug 15
Business combination disclosure
12:00am
425
pa6ed2zo 8eidu6
4 Aug 15
Business combination disclosure
12:00am
8-K
i57t0bge vu
4 Aug 15
Shire Proposes Combination with Baxalta to Create the Leading Global Biotech Company Focused on Rare Diseases
12:00am
8-K
wmzk nrp3r2v
3 Aug 15
Other Events
12:00am